Daniel Cressy
Coverage of Daniel Cressy in the Nexus archive.
- Louisiana man becomes first in state functionally cured of sickle cell disease
Daniel Cressy, a 23-year-old Louisiana man, became the first person in his state to be functionally cured of sickle cell disease through gene therapy at Manning Family Children’s Hospital in New Orleans. The treatment enables him to pursue his career as a commercial pilot, and Louisiana has the highest rate of sickle cell disease cases in the US.
- Gene therapy cures metro New Orleans man of sickle cell, clears path for dream of becoming pilot
Daniel Cressy, a 23-year-old from Metairie, became the first patient in the Gulf South to be functionally cured of sickle cell disease through gene editing. The treatment, using FDA-approved therapies Casgevy and Lyfgenia, involved a $2.2 million process including stem cell extraction and chemotherapy, with Cressy now experiencing normal hemoglobin and no sickling cells.
- 23-year-old becomes first in state functionally cured of sickle cell disease
A 23-year-old New Orleans man became the first in Louisiana to be functionally cured of sickle cell disease through gene therapy. Daniel Cressy underwent the treatment at Manning Family Children’s Hospital and now plans to establish a nonprofit to support others with the disease.
- 23-year-old becomes first in state functionally cured of sickle cell disease
A 23-year-old New Orleans man, Daniel Cressy, became the first person in Louisiana to be functionally cured of sickle cell disease through gene therapy. The procedure, conducted at Manning Family Children’s Hospital, involved editing his stem cells to eliminate the defective cells causing the disease, with Cressy now planning to support others through his nonprofit.
- 23-year-old becomes first in state functionally cured of sickle cell disease
Daniel Cressy, a 23-year-old from Louisiana, is the first in the state to be functionally cured of sickle cell disease via gene therapy at Manning Family Children’s Hospital. The procedure used his own edited stem cells, and he aims to launch a nonprofit to support others undergoing similar treatment.